Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

New quantitative approach reveals heterogeneity in mitochondrial structure-function relations in tumor-initiating cells.

Spurlock B, Gupta P, Basu MK, Mukherjee A, Hjelmeland AB, Darley-Usmar V, Parker D, Foxall ME, Mitra K.

J Cell Sci. 2019 May 2;132(9). pii: jcs230755. doi: 10.1242/jcs.230755.

PMID:
30910831
2.

Grammar of protein domain architectures.

Yu L, Tanwar DK, Penha EDS, Wolf YI, Koonin EV, Basu MK.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3636-3645. doi: 10.1073/pnas.1814684116. Epub 2019 Feb 7.

3.

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma.

Ping Z, Soni A, Williams LA 3rd, Pham HP, Basu MK, Zheng XL.

TH Open. 2017 Jul;1(2):e113-e121. doi: 10.1055/s-0037-1607337.

4.

Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients.

Tanwar DK, Parker DJ, Gupta P, Spurlock B, Alvarez RD, Basu MK, Mitra K.

Oncotarget. 2016 Sep 13;7(37):60021-60037. doi: 10.18632/oncotarget.11047.

5.

A new mitochondrial pool of cyclin E, regulated by Drp1, is linked to cell-density-dependent cell proliferation.

Parker DJ, Iyer A, Shah S, Moran A, Hjelmeland AB, Basu MK, Liu R, Mitra K.

J Cell Sci. 2015 Nov 15;128(22):4171-82. doi: 10.1242/jcs.172429. Epub 2015 Oct 7.

6.

Computational methods and resources for the interpretation of genomic variants in cancer.

Tian R, Basu MK, Capriotti E.

BMC Genomics. 2015;16 Suppl 8:S7. doi: 10.1186/1471-2164-16-S8-S7. Epub 2015 Jun 18. Review.

7.

ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.

Tian R, Basu MK, Capriotti E.

Bioinformatics. 2014 Sep 1;30(17):i572-8. doi: 10.1093/bioinformatics/btu466.

8.

Draft Genome Sequence of Pseudomonas sp. Strain Ant30-3, a Psychrotolerant Bacterium with Biodegradative Attribute Isolated from Antarctica.

Koo H, Basu MK, Crowley M, Aislabie J, Bej AK.

Genome Announc. 2014 Jun 5;2(3). pii: e00522-14. doi: 10.1128/genomeA.00522-14.

9.

TIGRFAMs and Genome Properties in 2013.

Haft DH, Selengut JD, Richter RA, Harkins D, Basu MK, Beck E.

Nucleic Acids Res. 2013 Jan;41(Database issue):D387-95. doi: 10.1093/nar/gks1234. Epub 2012 Nov 28.

10.

ProPhylo: partial phylogenetic profiling to guide protein family construction and assignment of biological process.

Basu MK, Selengut JD, Haft DH.

BMC Bioinformatics. 2011 Nov 9;12:434. doi: 10.1186/1471-2105-12-434.

11.
12.

The ecoresponsive genome of Daphnia pulex.

Colbourne JK, Pfrender ME, Gilbert D, Thomas WK, Tucker A, Oakley TH, Tokishita S, Aerts A, Arnold GJ, Basu MK, Bauer DJ, Cáceres CE, Carmel L, Casola C, Choi JH, Detter JC, Dong Q, Dusheyko S, Eads BD, Fröhlich T, Geiler-Samerotte KA, Gerlach D, Hatcher P, Jogdeo S, Krijgsveld J, Kriventseva EV, Kültz D, Laforsch C, Lindquist E, Lopez J, Manak JR, Muller J, Pangilinan J, Patwardhan RP, Pitluck S, Pritham EJ, Rechtsteiner A, Rho M, Rogozin IB, Sakarya O, Salamov A, Schaack S, Shapiro H, Shiga Y, Skalitzky C, Smith Z, Souvorov A, Sung W, Tang Z, Tsuchiya D, Tu H, Vos H, Wang M, Wolf YI, Yamagata H, Yamada T, Ye Y, Shaw JR, Andrews J, Crease TJ, Tang H, Lucas SM, Robertson HM, Bork P, Koonin EV, Zdobnov EM, Grigoriev IV, Lynch M, Boore JL.

Science. 2011 Feb 4;331(6017):555-61. doi: 10.1126/science.1197761.

13.

Novel disubstituted chrysene as a potent agent against colon cancer.

Banik BK, Basu MK, Becker FF.

Oncol Lett. 2010 Nov;1(6):1033-1035. Epub 2010 Sep 8.

14.

Expansion of ribosomally produced natural products: a nitrile hydratase- and Nif11-related precursor family.

Haft DH, Basu MK, Mitchell DA.

BMC Biol. 2010 May 25;8:70. doi: 10.1186/1741-7007-8-70.

15.

Domain mobility in proteins: functional and evolutionary implications.

Basu MK, Poliakov E, Rogozin IB.

Brief Bioinform. 2009 May;10(3):205-16. doi: 10.1093/bib/bbn057. Epub 2009 Jan 16.

16.
17.

Primordial spliceosomal introns were probably U2-type.

Basu MK, Rogozin IB, Koonin EV.

Trends Genet. 2008 Nov;24(11):525-8. doi: 10.1016/j.tig.2008.09.002. Epub 2008 Sep 27.

18.

U12 intron positions are more strongly conserved between animals and plants than U2 intron positions.

Basu MK, Makalowski W, Rogozin IB, Koonin EV.

Biol Direct. 2008 May 14;3:19. doi: 10.1186/1745-6150-3-19.

19.

Evolution of protein domain promiscuity in eukaryotes.

Basu MK, Carmel L, Rogozin IB, Koonin EV.

Genome Res. 2008 Mar;18(3):449-61. doi: 10.1101/gr.6943508. Epub 2008 Jan 29.

20.

Evolutionary dynamics of introns in plastid-derived genes in plants: saturation nearly reached but slow intron gain continues.

Basu MK, Rogozin IB, Deusch O, Dagan T, Martin W, Koonin EV.

Mol Biol Evol. 2008 Jan;25(1):111-9. Epub 2007 Oct 31.

PMID:
17974547
21.

Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis.

Mandal AK, Das S, Basu MK, Chakrabarti RN, Das N.

J Pharmacol Exp Ther. 2007 Mar;320(3):994-1001. Epub 2006 Nov 30.

PMID:
17138861
22.
23.

Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis.

Babenko VN, Basu MK, Kondrashov FA, Rogozin IB, Koonin EV.

BMC Cancer. 2006 Feb 9;6:36.

24.

Designing and testing of an effective oil-in-water microemulsion drug delivery system for in vivo application.

Gupta S, Moulik SP, Lala S, Basu MK, Sanyal SK, Datta S.

Drug Deliv. 2005 Sep-Oct;12(5):267-73.

PMID:
16188725
25.

Macrophage and Leishmania: an unacceptable coexistence.

Basu MK, Ray M.

Crit Rev Microbiol. 2005;31(3):145-54. Review.

PMID:
16170905
26.

APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.

Rogozin IB, Basu MK, Jordan IK, Pavlov YI, Koonin EV.

Cell Cycle. 2005 Sep;4(9):1281-5. Epub 2005 Sep 6.

PMID:
16082223
27.

Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis.

Tyagi R, Lala S, Verma AK, Nandy AK, Mahato SB, Maitra A, Basu MK.

J Drug Target. 2005 Apr;13(3):161-71.

PMID:
16036304
28.
29.

Macrophage specific drug delivery in experimental leishmaniasis.

Basu MK, Lala S.

Curr Mol Med. 2004 Sep;4(6):681-9. Review.

PMID:
15357216
30.

Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems.

Lala S, Pramanick S, Mukhopadhyay S, Bandyopadhyay S, Basu MK.

J Drug Target. 2004 Apr;12(3):165-75.

PMID:
15203896
31.

Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis.

Medda S, Jaisankar P, Manna RK, Pal B, Giri VS, Basu MK.

J Drug Target. 2003 Feb;11(2):123-8.

PMID:
12881199
32.

Delivery in vivo of 14-deoxy-11-oxoandrographolide, an antileishmanial agent, by different drug carriers.

Lala S, Nandy AK, Mahato SB, Basu MK.

Indian J Biochem Biophys. 2003 Jun;40(3):169-74.

PMID:
22900306
33.

Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes.

Sarkar S, Mandal S, Sinha J, Mukhopadhyay S, Das N, Basu MK.

J Drug Target. 2002 Dec;10(8):573-8.

PMID:
12683660
35.

Bacopasaponin C: critical evaluation of anti-leishmanial properties in various delivery modes.

Sinha J, Raay B, Das N, Medda S, Garai S, Mahato SB, Basu MK.

Drug Deliv. 2002 Jan-Mar;9(1):55-62.

PMID:
11839209
36.
37.

Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain.

Sinha J, Das N, Basu MK.

Biomed Pharmacother. 2001 Jun;55(5):264-71.

PMID:
11428552
38.
39.

fMLP receptor stimulated activation of macrophage: its effect on killing of intracellular Leishmania donovani.

Dasgupta D, Chakraborty P, Basu MK.

Biosci Rep. 2000 Oct;20(5):345-54.

PMID:
11332597
40.

Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo.

Sinha J, Mukhopadhyay S, Das N, Basu MK.

Drug Deliv. 2000 Oct-Dec;7(4):209-13.

PMID:
11195427
41.

Ligation of Fc receptor of macrophages stimulates protein kinase C and anti-leishmanial activity.

Dasgupta D, Chakraborty P, Basu MK.

Mol Cell Biochem. 2000 Jun;209(1-2):1-8.

PMID:
10942195
42.
43.
44.

Effect of angiotensin II on liposome uptake by the rat brain in vivo.

Das N, Raay B, Basu MK.

Indian J Exp Biol. 1999 Sep;37(9):871-5.

PMID:
10687281
45.

Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis.

Raay B, Medda S, Mukhopadhyay S, Basu MK.

Indian J Biochem Biophys. 1999 Aug;36(4):248-51.

PMID:
10650726
46.
47.

Synthesis and structure-activity relationships of potential anticancer agents: alkylcarbamates of 3-(9-acridinylamino)-5-hydroxymethylaniline.

Su TL, Chen CH, Huang LF, Chen CH, Basu MK, Zhang XG, Chou TC.

J Med Chem. 1999 Nov 18;42(23):4741-8.

PMID:
10579838
48.

Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

Chakraborty R, Dasgupta D, Adhya S, Basu MK.

Biochem J. 1999 Jun 1;340 ( Pt 2):393-6.

49.

Railways and municipalities in western Bengal.

Basu MK.

Bengal Past Present. 1999;118(1):54-75. No abstract available.

PMID:
19415887
50.

Macrophage mannosyl fucosyl receptor: its role in invasion of virulent and avirulent L. donovani promastigotes.

Chakraborty R, Chakraborty P, Basu MK.

Biosci Rep. 1998 Jun;18(3):129-42.

PMID:
9798785

Supplemental Content

Support Center